Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New appointments at Watson

This article was originally published in Scrip

Robert Stewart has joined Watson Pharmaceuticals (US) as senior vice-president of global operations. Mr Stewart, who will be responsible for global manufacturing, supply chain, quality and technical operations, joins after an eight-year career at Abbott Laboratories, where he was most recently divisional vice-president of global supply chain. Thomas Russillo, executive vice-president and president of Watson's generics division, has also been named executive vice-president of global generics and will head the company's newly formed global generics commercial function. He will have overall responsibility for generic sales and marketing in the US and Canada, as well for all international markets.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC005628

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel